COVID-19 Associated Mucormycosis: A Multidisciplinary Dilemma in Assiut University Hospital

Brief Title

COVID-19 Associated Mucormycosis: A Multidisciplinary Dilemma in Assiut University Hospital

Official Title

COVID-19 Associated Mucormycosis: A Multidisciplinary Dilemma in Assiut University Hospital

Brief Summary

      We aimed to describe the frequency; presentations, predictors, in-hospital outcome of
      mucormycosis patients in the scope of COVID-19.

      All patients with COVID-19 associated Mucormycosis (CAM) admitted to Assuit University
      Hospital between March 1, 2021, and July 30, 2021, were included in this study. The patient
      characteristics, the site of mucormycosis, the comorbidities, the steroids usage, and the
      outcome were analyzed in people with COVID-19.
    



Study Type

Observational


Primary Outcome

incidence of covid19 associated mucor


Condition

Mucormycosis

Intervention

antiviral, surgical

Study Arms / Comparison Groups

 covid19
Description:  covid 19 proven by clinical, PCR. not associated with mucor

Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information


Recruitment Status

Combination Product

Estimated Enrollment

433

Start Date

March 1, 2021

Completion Date

July 30, 2021

Primary Completion Date

June 30, 2021

Eligibility Criteria

        Inclusion Criteria:We recruited all cases admitted to Assuit University Hospital for the
        management of COVID-19 and/or associated complications between March 1, 2021, and July 30,
        2021, specifically those with probable mucormycosis based on clinical condition. At various
        times, internists, intensivists, neurologists, and otolaryngologists were among the
        specialists who assessed and treated them. Clinical; radiological and histopathological
        confirmed cases of mucormycosis with coexisting or previous history of COVID-19 were
        included in this study.

        -

        Exclusion Criteria:Participants with fungal infections other than mucormycosis or without a
        confirmed diagnosis of COVID-19 (or serological evidence of preceding COVID-19) were
        excluded.

        -
      

Gender

All

Ages

N/A - N/A

Accepts Healthy Volunteers

No

Contacts

, , 

Location Countries

Egypt

Location Countries

Egypt

Administrative Informations


NCT ID

NCT05074043

Organization ID

COVID-19 with mucormycosis


Responsible Party

Principal Investigator

Study Sponsor

Assiut University


Study Sponsor

, , 


Verification Date

October 2021